Adaptive Biotechnologies (ADPT) Cash from Operations (QoQ) (2018 - 2026)
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) Cash from Operations (QoQ) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.89% |
| Mar 31, 2026 | -564.09% |
| Dec 31, 2025 | 128.83% |
| Sep 30, 2025 | 42.66% |
| Jun 30, 2025 | 56.36% |
| Mar 31, 2025 | -128.04% |
| Dec 31, 2024 | 53.85% |
| Sep 30, 2024 | -56.42% |
| Jun 30, 2024 | 54.88% |
| Mar 31, 2024 | -42.41% |
| Dec 31, 2023 | 42.31% |
| Sep 30, 2023 | -98.18% |
| Jun 30, 2023 | 60.18% |
| Mar 31, 2023 | -97.05% |
| Dec 31, 2022 | 29.21% |
| Sep 30, 2022 | 9.89% |
| Jun 30, 2022 | 26.98% |
| Mar 31, 2022 | -19.74% |
| Dec 31, 2021 | -23.90% |
| Sep 30, 2021 | -16.74% |